Effect of proline mutations on the monomer conformations of amylin.

The formation of human islet amyloid polypeptide (hIAPP) is implicated in the loss of pancreatic β-cells in type II diabetes. Rat amylin, which differs from human amylin at six residues, does not lead to formation of amyloid fibrils. Pramlintide is a synthetic analog of human amylin that shares three proline substitutions with rat amylin. Pramlintide has a much smaller propensity to form amyloid aggregates and has been widely prescribed in amylin replacement treatment. It is known that the three prolines attenuate β-sheet formation. However, the detailed effects of these proline substitutions on full-length hIAPP remain poorly understood. In this work, we use molecular simulations and bias-exchange metadynamics to investigate the effect of proline substitutions on the conformation of the hIAPP monomer. Our results demonstrate that hIAPP can adopt various β-sheet conformations, some of which have been reported in experiments. The proline substitutions perturb the formation of long β-sheets and reduce their stability. More importantly, we find that all three proline substitutions of pramlintide are required to inhibit β conformations and stabilize the α-helical conformation. Fewer substitutions do not have a significant inhibiting effect.

[1]  D. Raleigh,et al.  Destabilization of human IAPP amyloid fibrils by proline mutations outside of the putative amyloidogenic domain: is there a critical amyloidogenic domain in human IAPP? , 2006, Journal of molecular biology.

[2]  M. Parrinello,et al.  Polymorphic transitions in single crystals: A new molecular dynamics method , 1981 .

[3]  D. Raleigh,et al.  Role of aromatic interactions in amyloid formation by peptides derived from human Amylin. , 2004, Biochemistry.

[4]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[5]  Chris Oostenbrink,et al.  A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force‐field parameter sets 53A5 and 53A6 , 2004, J. Comput. Chem..

[6]  J. Bernhagen,et al.  Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. , 1999, Journal of molecular biology.

[7]  David Eisenberg,et al.  Atomic structure of the cross‐β spine of islet amyloid polypeptide (amylin) , 2008, Protein science : a publication of the Protein Society.

[8]  Hoover,et al.  Canonical dynamics: Equilibrium phase-space distributions. , 1985, Physical review. A, General physics.

[9]  P. Argos,et al.  Knowledge‐based protein secondary structure assignment , 1995, Proteins.

[10]  Massimiliano Bonomi,et al.  PLUMED: A portable plugin for free-energy calculations with molecular dynamics , 2009, Comput. Phys. Commun..

[11]  E. T. Bell Hyalinization of the Islets of Langerhans in Diabetes Mellitus , 1952, Diabetes.

[12]  Per Westermark,et al.  Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. , 2011, Physiological reviews.

[13]  R. Holman,et al.  Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. , 1988, Diabetes research.

[14]  A. Alexandrescu,et al.  Dynamic α-Helix Structure of Micelle-bound Human Amylin* , 2009, Journal of Biological Chemistry.

[15]  A. Miranker,et al.  Direct detection of transient alpha-helical states in islet amyloid polypeptide. , 2007, Protein science : a publication of the Protein Society.

[16]  C. Betsholtz,et al.  Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[17]  P. Westermark,et al.  The pancreatic islet cells in insular amyloidosis in human diabetic and non-diabetic adults. , 2009, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.

[18]  J. Pablo,et al.  Hyperparallel tempering Monte Carlo simulation of polymeric systems , 2000 .

[19]  D. Raleigh,et al.  Analysis of amylin cleavage products provides new insights into the amyloidogenic region of human amylin. , 1999, Journal of molecular biology.

[20]  Alessandro Laio,et al.  A Collective Variable for the Efficient Exploration of Protein Beta-Sheet Structures: Application to SH3 and GB1. , 2009, Journal of chemical theory and computation.

[21]  Lu Wang,et al.  Solution structures of rat amylin peptide: simulation, theory, and experiment. , 2010, Biophysical journal.

[22]  Berk Hess,et al.  LINCS: A linear constraint solver for molecular simulations , 1997, J. Comput. Chem..

[23]  D. Raleigh,et al.  Aggregation of islet amyloid polypeptide: from physical chemistry to cell biology. , 2013, Current opinion in structural biology.

[24]  Kenneth H. Johnson,et al.  Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains differences in islet amyloid formation between species , 1989, FEBS letters.

[25]  García,et al.  Large-amplitude nonlinear motions in proteins. , 1992, Physical review letters.

[26]  Bruce A. Yankner,et al.  Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus , 1994, Nature.

[27]  Peter Marek,et al.  Two-dimensional infrared spectroscopy reveals the complex behavior of an amyloid fibril inhibitor , 2012, Nature chemistry.

[28]  S. Nosé A molecular dynamics method for simulations in the canonical ensemble , 1984 .

[29]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[30]  A. Miranker,et al.  The interplay of catalysis and toxicity by amyloid intermediates on lipid bilayers: insights from type II diabetes. , 2009, Annual review of biophysics.

[31]  John R Cort,et al.  Solution state structures of human pancreatic amylin and pramlintide. , 2009, Protein engineering, design & selection : PEDS.

[32]  R. Turner,et al.  ISLET AMYLOID FORMED FROM DIABETES-ASSOCIATED PEPTIDE MAY BE PATHOGENIC IN TYPE-2 DIABETES , 1987, The Lancet.

[33]  Carsten Kutzner,et al.  GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. , 2008, Journal of chemical theory and computation.

[34]  M. Nakazato,et al.  Isolation and sequence determination of ratislet amyloid polypeptide , 1989 .

[35]  Berg,et al.  Multicanonical ensemble: A new approach to simulate first-order phase transitions. , 1992, Physical review letters.

[36]  T. Darden,et al.  A smooth particle mesh Ewald method , 1995 .

[37]  S. Nosé A unified formulation of the constant temperature molecular dynamics methods , 1984 .

[38]  U. Aebi,et al.  Full-length rat amylin forms fibrils following substitution of single residues from human amylin. , 2003, Journal of molecular biology.

[39]  Ian S. Haworth,et al.  Fibril Structure of Human Islet Amyloid Polypeptide*♦ , 2011, The Journal of Biological Chemistry.

[40]  Ueli Aebi,et al.  The parallel superpleated beta-structure as a model for amyloid fibrils of human amylin. , 2005, Journal of molecular biology.

[41]  A. Laio,et al.  A bias-exchange approach to protein folding. , 2007, The journal of physical chemistry. B.

[42]  D. Steiner,et al.  Effects of beta cell granule components on human islet amyloid polypeptide fibril formation , 1996, FEBS letters.

[43]  Kevin Hartman,et al.  Three-dimensional structure and orientation of rat islet amyloid polypeptide protein in a membrane environment by solution NMR spectroscopy. , 2009, Journal of the American Chemical Society.

[44]  Alessandro Laio,et al.  METAGUI. A VMD interface for analyzing metadynamics and molecular dynamics simulations , 2012, Comput. Phys. Commun..

[45]  Guizhao Liang,et al.  Comparative molecular dynamics study of human islet amyloid polypeptide (IAPP) and rat IAPP oligomers. , 2013, Biochemistry.

[46]  Alessandro Laio,et al.  A Kinetic Model of Trp-Cage Folding from Multiple Biased Molecular Dynamics Simulations , 2009, PLoS Comput. Biol..

[47]  L. Nilsson,et al.  Structure and Dynamics of the TIP3P, SPC, and SPC/E Water Models at 298 K , 2001 .

[48]  D. W. Hayden,et al.  Feline Insular Amyloid: Association with Diabetes Mellitus , 1981, Veterinary pathology.

[49]  Joan-Emma Shea,et al.  The amyloid formation mechanism in human IAPP: dimers have β-strand monomer-monomer interfaces. , 2011, Journal of the American Chemical Society.

[50]  J. Saldanha,et al.  Molecular model-building of amylin and alpha-calcitonin gene-related polypeptide hormones using a combination of knowledge sources. , 1991, Protein engineering.

[51]  Richard Leapman,et al.  Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR. , 2007, Biochemistry.

[52]  David Eisenberg,et al.  Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process , 2009, Protein science : a publication of the Protein Society.

[53]  C. Howard Insular Amyloidosis and Diabetes Mellitus in Macaca Nigra , 1978, Diabetes.

[54]  Juan J de Pablo,et al.  2DIR spectroscopy of human amylin fibrils reflects stable β-sheet structure. , 2011, Journal of the American Chemical Society.

[55]  R. Swendsen,et al.  THE weighted histogram analysis method for free‐energy calculations on biomolecules. I. The method , 1992 .

[56]  Alessandro Laio,et al.  Multidimensional view of amyloid fibril nucleation in atomistic detail. , 2012, Journal of the American Chemical Society.

[57]  H. Berendsen,et al.  Interaction Models for Water in Relation to Protein Hydration , 1981 .

[58]  Juan J de Pablo,et al.  Density of states-based molecular simulations. , 2012, Annual review of chemical and biomolecular engineering.

[59]  G. Ryan,et al.  Pramlintide in the treatment of type 1 and type 2 diabetes mellitus. , 2005, Clinical therapeutics.

[60]  A. Laio,et al.  Escaping free-energy minima , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[61]  A. Clark,et al.  Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology. , 2001, Biochimica et biophysica acta.

[62]  A. Miranker,et al.  Conserved and cooperative assembly of membrane-bound alpha-helical states of islet amyloid polypeptide. , 2006, Biochemistry.

[63]  O G Kolterman,et al.  Amylin replacement with pramlintide as an adjunct to insulin therapy improves long‐term glycaemic and weight control in Type 1 diabetes mellitus: a 1‐year, randomized controlled trial , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[64]  L. Sutherland,et al.  The pancreas in the degu. , 1984, Experimental and molecular pathology.

[65]  P E Fraser,et al.  Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis. , 2001, Journal of molecular biology.

[66]  D. Raleigh,et al.  Effects of sequential proline substitutions on amyloid formation by human amylin20-29. , 1999, Biochemistry.

[67]  G. Glenner,et al.  Amyloid fibrils formed from a segment of the pancreatic islet amyloid protein. , 1988, Biochemical and biophysical research communications.

[68]  Joan-Emma Shea,et al.  Human islet amyloid polypeptide monomers form ordered beta-hairpins: a possible direct amyloidogenic precursor. , 2009, Journal of the American Chemical Society.

[69]  A. Laio,et al.  Metadynamics: a method to simulate rare events and reconstruct the free energy in biophysics, chemistry and material science , 2008 .

[70]  J. MacQueen Some methods for classification and analysis of multivariate observations , 1967 .

[71]  Juan J de Pablo,et al.  Stable and metastable states of human amylin in solution. , 2010, Biophysical journal.

[72]  A. R. Srinivasan,et al.  Quasi‐harmonic method for studying very low frequency modes in proteins , 1984, Biopolymers.

[73]  E. Wilander,et al.  The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus , 1978, Diabetologia.